Biomedical subjects
S Ozsoylu
Publications and source records attributed to S Ozsoylu.
Megadose methylprednisolone for Kasabach-Merritt syndrome.
Explore the source record for details and available documents.
Is mitomycin C-induced chromosome breakage always required for the diagnosis of Fanconi aplastic anemia?
Explore the source record for details and available documents.
Transient hypoplastic anemia of childhood.
Explore the source record for details and available documents.
Niemann-Pick disease and neonatal hepatitis.
Explore the source record for details and available documents.
Budd-Chiari syndrome in childhood.
Explore the source record for details and available documents.
Primary sclerosing cholangitis in children.
Explore the source record for details and available documents.
High-dose methylprednisolone for the treatment of priapism in childhood leukemia.
Explore the source record for details and available documents.
Idiopathic thrombocytopenic purpura in infants.
Explore the source record for details and available documents.
About the treatment of childhood chronic idiopathic thrombocytopenic purpura.
Explore the source record for details and available documents.
Acceleration of leukocyte recovery by administration of short-course high-dose methylprednisolone in children with acute lymphoblastic leukemia.
Explore the source record for details and available documents.
History and present state of pediatric hematology and oncology in Turkey.
Explore the source record for details and available documents.
Megadose methylprednisolone for Kasabach-Merritt syndrome.
Explore the source record for details and available documents.
Immunology of childhood acute idiopathic thrombocytopenic purpura.
Explore the source record for details and available documents.
Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
Twenty children with acute idiopathic thrombocytopenic purpura (ITP) were randomized to receive either oral megadose methylprednisolone (MDMP) or intravenous immunoglobulin G (IV IgG). Normal platelet counts (> or = 150 x 10(9)/l) were obtained in 6 patients of each group in 3 days and in 8 and 9 patients treated with oral MDMP and with IV IgG within 1 week, respectively. It is concluded that oral MDMP could easily be used for the early elevation of platelet counts, which is important for ITP treatment.
Malignant osteopetrosis and juvenile chronic myeloid leukemia.
Explore the source record for details and available documents.
Oral megadose methylprednisolone for the treatment of Diamond-Blackfan anemia.
Explore the source record for details and available documents.